United States Inhalation and Nasal Spray Generic Drugs Market Report 2017

United States Inhalation and Nasal Spray Generic Drugs Market Report 2017

1 Inhalation and Nasal Spray Generic Drugs Overview

1.1 Product Overview and Scope of Inhalation and Nasal Spray Generic Drugs

1.2 Classification of Inhalation and Nasal Spray Generic Drugs by Product Category

1.2.1 United States Inhalation and Nasal Spray Generic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Inhalation and Nasal Spray Generic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Corticosteroids

1.2.4 Bronchodilators

1.2.5 Antihistamines

1.2.6 Combinations

1.2.7 Decongestant Sprays

1.3 United States Inhalation and Nasal Spray Generic Drugs Market by Application/End Users

1.3.1 United States Inhalation and Nasal Spray Generic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Asthma

1.3.3 COPD

1.3.4 Allergic Rhinitis

1.3.5 Other Respiratory Disorders

1.4 United States Inhalation and Nasal Spray Generic Drugs Market by Region

1.4.1 United States Inhalation and Nasal Spray Generic Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.4.5 New England Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.4.6 The South Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Inhalation and Nasal Spray Generic Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Inhalation and Nasal Spray Generic Drugs (2012-2022)

1.5.1 United States Inhalation and Nasal Spray Generic Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Inhalation and Nasal Spray Generic Drugs Revenue and Growth Rate (2012-2022)

2 United States Inhalation and Nasal Spray Generic Drugs Market Competition by Players/Suppliers

2.1 United States Inhalation and Nasal Spray Generic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Inhalation and Nasal Spray Generic Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Inhalation and Nasal Spray Generic Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Inhalation and Nasal Spray Generic Drugs Market Competitive Situation and Trends

2.4.1 United States Inhalation and Nasal Spray Generic Drugs Market Concentration Rate

2.4.2 United States Inhalation and Nasal Spray Generic Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Inhalation and Nasal Spray Generic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Inhalation and Nasal Spray Generic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Inhalation and Nasal Spray Generic Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Inhalation and Nasal Spray Generic Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Inhalation and Nasal Spray Generic Drugs Price by Region (2012-2017)

4 United States Inhalation and Nasal Spray Generic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Inhalation and Nasal Spray Generic Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Inhalation and Nasal Spray Generic Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Inhalation and Nasal Spray Generic Drugs Price by Type (2012-2017)

4.4 United States Inhalation and Nasal Spray Generic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Inhalation and Nasal Spray Generic Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Inhalation and Nasal Spray Generic Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Inhalation and Nasal Spray Generic Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Inhalation and Nasal Spray Generic Drugs Players/Suppliers Profiles and Sales Data

6.1 Teva Pharmaceutical

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Teva Pharmaceutical Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Sandoz

6.2.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Sandoz Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Allergan

6.3.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Allergan Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Mylan

6.4.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Mylan Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Ranbaxy Laboraotries

6.5.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Ranbaxy Laboraotries Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Roxane Laboratories

6.6.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Roxane Laboratories Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Beximco Pharmaceuticals

6.7.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Beximco Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Cipla

6.8.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Cipla Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Nephron Pharmaceuticals

6.9.2 Inhalation and Nasal Spray Generic Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Nephron Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

7 Inhalation and Nasal Spray Generic Drugs Manufacturing Cost Analysis

7.1 Inhalation and Nasal Spray Generic Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Inhalation and Nasal Spray Generic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Inhalation and Nasal Spray Generic Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Inhalation and Nasal Spray Generic Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Inhalation and Nasal Spray Generic Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Inhalation and Nasal Spray Generic Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Inhalation and Nasal Spray Generic Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Inhalation and Nasal Spray Generic Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Inhalation and Nasal Spray Generic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Inhalation and Nasal Spray Generic Drugs

Figure United States Inhalation and Nasal Spray Generic Drugs Market Size (K Pcs) by Type (2012-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Corticosteroids Product Picture

Figure Bronchodilators Product Picture

Figure Antihistamines Product Picture

Figure Combinations Product Picture

Figure Decongestant Sprays Product Picture

Figure United States Inhalation and Nasal Spray Generic Drugs Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Inhalation and Nasal Spray Generic Drugs by Application in 2016

Figure Asthma Examples

Figure COPD Examples

Figure Allergic Rhinitis Examples

Figure Other Respiratory Disorders Examples

Figure United States Inhalation and Nasal Spray Generic Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Inhalation and Nasal Spray Generic Drugs Sales Share by Players/Suppliers

Figure 2017 United States Inhalation and Nasal Spray Generic Drugs Sales Share by Players/Suppliers

Figure United States Inhalation and Nasal Spray Generic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Inhalation and Nasal Spray Generic Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Inhalation and Nasal Spray Generic Drugs Revenue Share by Players/Suppliers

Table United States Market Inhalation and Nasal Spray Generic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Inhalation and Nasal Spray Generic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Inhalation and Nasal Spray Generic Drugs Market Share of Top 3 Players/Suppliers

Figure United States Inhalation and Nasal Spray Generic Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Inhalation and Nasal Spray Generic Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Inhalation and Nasal Spray Generic Drugs Product Category

Table United States Inhalation and Nasal Spray Generic Drugs Sales (K Pcs) by Region (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Share by Region (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Share by Region (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Market Share by Region in 2016

Table United States Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Revenue Share by Region (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Region (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Revenue Market Share by Region in 2016

Table United States Inhalation and Nasal Spray Generic Drugs Price (USD/Pcs) by Region (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales (K Pcs) by Type (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Share by Type (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Share by Type (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Market Share by Type in 2016

Table United States Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Inhalation and Nasal Spray Generic Drugs by Type (2012-2017)

Figure Revenue Market Share of Inhalation and Nasal Spray Generic Drugs by Type in 2016

Table United States Inhalation and Nasal Spray Generic Drugs Price (USD/Pcs) by Types (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Growth Rate by Type (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales (K Pcs) by Application (2012-2017)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Market Share by Application in 2016

Table United States Inhalation and Nasal Spray Generic Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Growth Rate by Application (2012-2017)

Table Teva Pharmaceutical Basic Information List

Table Teva Pharmaceutical Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Teva Pharmaceutical Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Teva Pharmaceutical Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Teva Pharmaceutical Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Sandoz Basic Information List

Table Sandoz Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sandoz Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Sandoz Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Sandoz Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Allergan Basic Information List

Table Allergan Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Allergan Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Allergan Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Allergan Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Mylan Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Mylan Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Mylan Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Ranbaxy Laboraotries Basic Information List

Table Ranbaxy Laboraotries Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Ranbaxy Laboraotries Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Ranbaxy Laboraotries Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Ranbaxy Laboraotries Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Roxane Laboratories Basic Information List

Table Roxane Laboratories Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Roxane Laboratories Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Roxane Laboratories Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Roxane Laboratories Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Beximco Pharmaceuticals Basic Information List

Table Beximco Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Beximco Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Beximco Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Beximco Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Cipla Basic Information List

Table Cipla Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Cipla Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Cipla Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Cipla Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Nephron Pharmaceuticals Basic Information List

Table Nephron Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Nephron Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales Growth Rate (2012-2017)

Figure Nephron Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Sales Market Share in United States (2012-2017)

Figure Nephron Pharmaceuticals Inhalation and Nasal Spray Generic Drugs Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Inhalation and Nasal Spray Generic Drugs

Figure Manufacturing Process Analysis of Inhalation and Nasal Spray Generic Drugs

Figure Inhalation and Nasal Spray Generic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Inhalation and Nasal Spray Generic Drugs Major Players/Suppliers in 2016

Table Major Buyers of Inhalation and Nasal Spray Generic Drugs

Table Distributors/Traders List

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Inhalation and Nasal Spray Generic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Inhalation and Nasal Spray Generic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Inhalation and Nasal Spray Generic Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources